AbbVie ABBV Invested capital
Discontinued — last reported Q4 '25
Invested capital at other companies
Other financials
Where this comes from
Calculated from AbbVie’s reported figures.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's invested capital?
- AbbVie (ABBV) reported invested capital of $53.87B in Q4 2025.
- How has AbbVie's invested capital changed year-over-year?
- AbbVie's invested capital decreased by 8.8% year-over-year, from $59.06B to $53.87B.
- What is the long-term trend for AbbVie's invested capital?
- Over 5 years (2020 to 2025), AbbVie's invested capital has grown at a -8.3% compound annual growth rate (CAGR), from $83.25B to $53.87B.
- What does invested capital mean?
- The capital — debt plus equity, net of idle cash — that funds the operating business.
- How do you interpret invested capital?
- A level, read mainly through ROIC (NOPAT ÷ invested capital). Growing invested capital is only good if returns on it stay above the cost of capital.
- How does invested capital compare across companies?
- Used as the base for ROIC; the definition is sector-sensitive, so banks and insurers are best excluded.